Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents

ClinicalTrials.gov ID: NCT00011479

Public ClinicalTrials.gov record NCT00011479. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 12:30 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Single Dose Pharmacokinetic Study of Abacavir in HIV-Infected Children and Adolescents

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to measure blood levels of abacavir in children and adolescents over a period of time following a single dose so that a dosage for adolescents can be determined. Little is known about how abacavir is cleared by the body in adolescents. It has been shown that young children require a higher abacavir dose based on weight than adults. Older children, or adolescents, may not require as high a dose. This study may provide information as to whether the children's dose or the adult dose is better for HIV-infected adolescents.

Study identification

NCT ID
NCT00011479
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Enrollment
24 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
9 Years to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Aug 2002 (Actual)
Last update posted
Nov 1, 2021

Ends 2002

United States locations

U.S. sites
24
U.S. states
14
U.S. cities
21
Facility City State ZIP Site status
Univ of Alabama at Birmingham - Pediatric Birmingham Alabama 35233 —
Los Angeles County - USC Med Ctr Los Angeles California 90033 —
Children's Hospital of L.A. (Pediatric) Los Angeles California 90054 —
Univ of California, San Diego San Diego California 92103 —
Children's Hosp of Washington DC Washington D.C. District of Columbia 200102916 —
Univ of Florida Health Science Ctr / Pediatrics Jacksonville Florida 32209 —
Univ of Miami (Pediatric) Miami Florida 33161 —
Med College of Georgia Augusta Georgia 30912 —
The Med Ctr Inc Columbus Georgia 31901 —
Cook County Hosp Chicago Illinois 60612 —
Chicago Children's Memorial Hosp Chicago Illinois 606143394 —
Univ of Chicago Children's Hosp Chicago Illinois 606371470 —
Children's Hosp of Boston Boston Massachusetts 021155724 —
Univ of Medicine & Dentistry of New Jersey / Univ Hosp Newark New Jersey 071032714 —
Metropolitan Hosp Ctr New York New York 10029 —
Univ of Rochester Med Ctr Rochester New York 146420001 —
State Univ of New York at Stony Brook Stony Brook New York 117948111 —
Montefiore Med Ctr Adolescent AIDS Program The Bronx New York 10467 —
Duke Univ Med Ctr Durham North Carolina 277103499 —
Columbus Children's Hosp Columbus Ohio 432052696 —
Med Univ of South Carolina Charleston South Carolina 294253312 —
Saint Jude Children's Research Hosp of Memphis Memphis Tennessee 381052794 —
Children's Med Ctr of Dallas Dallas Texas 75235 —
Texas Children's Hosp / Baylor Univ Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00011479, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2021 · Synced Nov 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00011479 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →